Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · IEX Real-Time Price · USD
3.080
-0.100 (-3.14%)
At close: Jul 19, 2024, 4:00 PM
3.100
+0.020 (0.65%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Harvard Bioscience Market Cap
Harvard Bioscience has a market cap or net worth of $133.76 million as of July 22, 2024. Its market cap has decreased by -42.66% in one year.
Market Cap
133.76M
Enterprise Value
170.87M
1-Year Change
-42.66%
Ranking
Category
Stock Price
$3.08
Market Cap Chart
Since March 19, 2001, Harvard Bioscience's market cap has decreased from $173.50M to $133.76M, a decrease of -22.90%. That is a compound annual growth rate of -1.11%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 133.80M | -41.42% |
Dec 29, 2023 | 228.40M | 97.92% |
Dec 30, 2022 | 115.40M | -59.89% |
Dec 31, 2021 | 287.70M | 72.07% |
Dec 31, 2020 | 167.20M | 44.01% |
Dec 31, 2019 | 116.10M | -2.11% |
Dec 31, 2018 | 118.60M | 3.04% |
Dec 29, 2017 | 115.10M | 9.83% |
Dec 30, 2016 | 104.80M | -11.04% |
Dec 31, 2015 | 117.80M | -35.91% |
Dec 31, 2014 | 183.80M | 26.15% |
Dec 31, 2013 | 145.70M | 15.45% |
Dec 31, 2012 | 126.20M | 14.42% |
Dec 30, 2011 | 110.30M | -4.42% |
Dec 31, 2010 | 115.40M | 9.70% |
Dec 31, 2009 | 105.20M | 29.08% |
Dec 31, 2008 | 81.50M | -42.24% |
Dec 31, 2007 | 141.10M | -9.96% |
Dec 29, 2006 | 156.70M | 15.56% |
Dec 30, 2005 | 135.60M | -3.49% |
Dec 31, 2004 | 140.50M | -47.56% |
Dec 31, 2003 | 267.90M | 170.88% |
Dec 31, 2002 | 98.90M | -62.67% |
Dec 31, 2001 | 264.90M | 52.68% |
Mar 19, 2001 | 173.50M | - |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Corvus Pharmaceuticals | 136.36M |
Electromed | 136.24M |
Inventiva | 136.16M |
CervoMed | 134.12M |
DIH Holdings US | 133.80M |
Tevogen Bio Holdings | 133.36M |
Veru Inc. | 132.29M |
Compass Therapeutics | 128.89M |